❌

Normal view

Received — 27 May 2026 ⏭ Journals

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8<sup>+</sup> memory T cell responses

✇Oncogenesis - nature.com science feeds
By: Gao Yu · Yusheng Liang · Weize Yu · Gaojian Zhuang · Bing Li · Jiayi Huang · Jinghao Zheng · Xuanqi Yang · Leyun Wen · Xiaoming Tan · Yuan Zhang
15 May 2026 at 08:00

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00627-z

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8+ memory T cell responses
Received — 13 April 2026 ⏭ Journals
Received — 2 April 2026 ⏭ Journals

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

✇Nature Medicine
By: Princess U. Ogbogu · Florence Roufosse · Praveen Akuthota · Piotr Kuna · Matthieu Groh · Andreas Reiter · Akira Yokota · Salman H. Siddiqui · Pim G. N. J. Mutsaers · Bing Li · Paneez Khoury · Lila M. Bahadori · Artur Bednarczyk · Gerben Bouma · Laura G. Brooks · Jorge Ferreira · Hanna Grindebacke · Calvin N. Ho · Priya Jain · Rebecca L. Palmer · Maria L. Jison · Amy D. Klion
31 March 2026 at 08:00

Nature Medicine, Published online: 31 March 2026; doi:10.1038/s41591-026-04315-8

Benralizumab (an anti-IL-5 receptor α antibody), compared to placebo, significantly reduced the risk of first flare in patients with hypereosinophilic syndrome.
Received — 14 March 2026 ⏭ Journals

Harnessing pyroptosis in breast cancer therapy: immunological mechanisms and emerging biomaterial strategies

✇Cell Death Discovery nature.com science feeds
By: Richmond Kwame Frimpong Asiedu · Mahamadou Souley Abdou · Rongbin Wei · Zhongdang Xiao · Bing Li · Ming Hu
12 March 2026 at 08:00

Cell Death Discovery, Published online: 12 March 2026; doi:10.1038/s41420-026-02996-1

Harnessing pyroptosis in breast cancer therapy: immunological mechanisms and emerging biomaterial strategies
There are no more articles
❌